Inactivating FBXW7 mutations are common in cancers driven by NOTCH1 activating mutations, such as T-cell acute lymphoblastic leukaemia (T-ALL) and chronic lymphocytic leukaemia (CLL)31. This evidence concerns the gene FBXW7 and T-cell acute lymphoblastic leukemia.